Dualistic Effects of PRKAR1A as a Potential Anticancer Target in Cancer Cells and Cancer-Derived Stem Cells
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25052876 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Joong-Won Baek und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Laboratory Science, Konyang University, Daejeon 35365, Republic of Korea. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF).
Abstract (Originalsprache)
The integration of innovative medical technologies and interdisciplinary collaboration could improve the treatment of cancer, a globally prevalent and often deadly disease. Despite recent advancements, current cancer therapies fail to specifically address recurrence and target cancer stem cells (CSCs), which contribute to relapse. In this study, we utilized three types of cancer cells, from which three types of CSCs were further derived, to conduct a proteomic analysis. Additionally, shared cell surface biomarkers were identified as potential targets for a comprehensive treatment strategy. The selected biomarkers were evaluated through short hairpin RNA treatment, which revealed contrasting functions in cancer cells and CSCs. Knockdown of the identified proteins revealed that they regulate the epithelial–mesenchymal transition (EMT) and stemness via the ERK signaling pathway. Resistance to anticancer agents was consequently reduced, ultimately enhancing the overall anticancer effects of the treatment. Additionally, the significance of these biomarkers in clinical patient outcomes was confirmed using bioinformatics. Our study suggests a novel cancer treatment strategy that addresses the limitations of current anticancer therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Laboratory Science, Konyang University, Daejeon 35365, Republic of Korea.
- Department of Veterinary Medicine, Seoul National University, Seoul 08826, Republic of Korea.
- Department of Convergence Medicine, Asan Medical Center, Seoul 05505, Republic of Korea.
ORCID-Profile: Kyunggon Kim, Pyung-Hwan Kim
Förderung
- National Research Foundation of Korea (NRF)
Zitieren
APA
Baek, J. W., Nam, A. R., Kim, K., & Kim, P. H. (2024). Dualistic Effects of PRKAR1A as a Potential Anticancer Target in Cancer Cells and Cancer-Derived Stem Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25052876
Vancouver
Baek JW, Nam AR, Kim K, Kim PH. Dualistic Effects of PRKAR1A as a Potential Anticancer Target in Cancer Cells and Cancer-Derived Stem Cells. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25052876
BibTeX
@article{Baek2024,
author = {Baek, Joong-Won and Nam, A-Reum and Kim, Kyunggon and Kim, Pyung-Hwan},
title = {Dualistic Effects of PRKAR1A as a Potential Anticancer Target in Cancer Cells and Cancer-Derived Stem Cells},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25052876}
}
EUVIMED